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   Osteogenic sarcoma was produced experimentally by the repeated 
injection of beryllium oxide (BeO) directly into the right femur of rabbits. 
Young rabbits weighing 1.5 kg on the average were injected with 1 cc of 
1.0 % suspension of beryllium oxide in physiologic saline solution. Ten 
rabbits were treated with a single injection of beryllium. Forty-three 
rabbits were twice a week for a total of divided into five groups. Of 30 
rabbits which survived for more than 9 months Twenty-five rabbits (84%) 
developed osteogenic sarcoma, chondrosarcoma or presarcomatous changes.
                  INTRODUCTION 
   Various tumors have been produced experimentally by many resea-
rchers since YAMAGIWA first produced in 1915. However, most of them 
are tumors other than those of the bone. This is probably based on 
the fact that the study of bone tumors was accompanied by more 
difficulties than that of soft tissue tumors. In 1946 GARDNER had 
produced osteogenic sarcomas in 7 rabbits by intravenous injection of 
a suspension of powdered alloy of beryllium, zinc and arsenic. This 
experiment was done accompanying the experimental study on the 
occupational disease, berylliosis, incidence of which was increasing 
among the workers in the factories of durable copper alloy goods such 
as radiation tubes, fluorescent lamps and vacuum tubes in which Bery-
llium was used in large amounts. This study became the start of the 
experimental study of bone tumors. The above fact attracted researchers 
attention to the pathological changes and its transition to tumor produ-
ced when beryllium compounds were administered. In the present study 
osteogenic sarcoma was produced experimentally by the repeated inje-
ction of beryllium oxide (BeO) directly into the bone marrow of rabbits. 
These induced sarcomas was studied histopathologically and histoche-
mically.
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Table 1. Conditions and results of the experiment.








Number Total Period from time of Period from timeNatural death classification of induced Size of tu
morsReference Animal o  BeO experimentalnumber number or slaughter I tumors (cm)injection period first notice of tumors tumors to death
1 43 1 ! 5 hrs N.D.
2 46 1 10 a 5
3 41 1 24 " 5 .
4 47 1 48
5 61 1 4 days 4 days S. Presarcomatoid change No gross change
6 58 1 7 " 5.
7 55 1 14 " 5 .
8 155 1 21 a S.
9 62 1 28 " 5 .
10 63 1 35 v 35 S Chondroma No gross change
11 48 3 56 ri N.D.
12 25 9 77 rr N.D.
13 53 3 j 160 " S.
14 45 7 217 " SI
15 42 11 111 "
16 19 17 117 rr
17 34 18 134 "
18 66 17 138 " S.
19 9 19 165 " N D
20 40 12 170 " N, D.
21 29 11 232 " N. D.
S Osteogenic sarcoma 2 x 1 x 122 70 13 270 " 60
5. Presarcomatoid change 2 x 2 x 123 44 13 307 ri 60
24 60 13 327 " I N DI
25 20 11 360 r~ 150 r 150 r S. Osteochondrosarcoma 7 x 6 x 5
26 26 19 360 " 13 rr 60 " S Osteogenic sarcoma 8 x 6 x 6


















sarcoma 4 x 3 x 228 56 19 380 /~ 20 /~ 30 /i N. D , i
st enic sarcoma 8 x 7 x 629 31 17 407
sarcoma 6 x 6 x 430 57 I 11 447 // 271 73 S. I
31 8 26 184 /~ N D
32 68 22 196 N. D .
5 x 5 x 433 27 24 327 /~ 20 30 / S.
, 34 30 22 330 /~ 68 / 57 / S.9 x 6 x 4
35 65 22 334 /~ 192 /~ 42 /~ S. Chondrosarcoma 7 x 6 x 4
8 x 7 x 636 33 25 340 " 33 // 67 // S.
sarcoma 10 x 7 x 737 35 24 352 /i 22 /~ 90 /i
38 16 27 360 // unknown unknown N.D.No gross change
39 37 26 385 // 85 dys 90 dyS.sarcoma 4 x 3 x 3
sarcoma 7 x 6 x 540 32 25 433 /i 133 60 S.
/~ , 60 43 S. Chondrosarcoma 10 x 9 x 741 36 30 463
sarcoma 3 x 2 x 242 39 21 534 " 151 /~ 21 a N.D.
43 50 22 638 /i 259 /i 81 /i N D ')steogenic sarcoma 5 x 5 x 3
44 14 31 249 " I N . D .
45 22 38 250 // S
46 15 39 285 // N . D .
N.D,47 17 40 293 //
48 18 38 296 // N . D .
49 13 39 340 // steochondrosarcoma 3 x 2 x 1
sarcoma 4 x 3 x 350 10 32 380 /~ 80 /~ 30 /i N.D.
, 51 67 31 394 // 205 r 39 r S. ')steogenic sarcoma 5 x 3 x 3
52 11 42 323 // unknown unknown N.D.sarcoma No gross change
53 12 41 324 // steochondrosarcoma No gross changeI
54 4 42 386 N . D .
55 3 43 578 /r 254 days 150 days 5 ')steogenic sarcoma 11 x 10 x 8
'
I
21 // 30 /r S. O
,
i
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              MATERIALS AND METHODS 
   Young rabbits weighing 1.5 kg on the average were injected with 
1 cc of 1.0 % suspension of beryllium oxide in physiologic saline solution 
into the metaphysis marrow of the right femur. As for the injector, a 
modified bone marrow aspirator was used. Ten rabbits were treated 
with a single injection of beryllium. Forty-five rabbits were given 
beryllium twice a week and divided into five groups : 2 -10 injections, 
11-20, 21-30, 31-40, and over 41. The induced tumors were cut into 
two, making two groups. No decalcification was done on one of the 
groups and this group was fixed in carnoy solution. The other group 
was fixed in 10% formalin as control. The other organs involved by 
metastasis were also examined microscopically. The sections were 
stained with H. E. ,. Azan staining (MALORY'S method), VAN GIESON, 
PAS, Methyl green Pyronine, FEULGEN reaction, SCHNEIDER' T. C. A., 
ERICKSON, SAx et OGUR' P. C. A. etc. The survival duration of the 
rabbits, frequency of injection and period from the initial injection to 
the production of tumors are shown in Table 1. 
                     RESULTS 
   I . Group treated with single injection : 
   The animal # 61 was slaughtered 4 days after single injection. In 
this case, an irregular proliferation of immature mesenchymal cells was 
seen around the injected Beryllium Oxide (hereafter abbreviated as 
BeO). This should be interpreted as presarcomatous change (Fig. 1). 
In other cases no evident findings consistent with tumor were seen. 
The experimental periods of these cases were much less than the total 
experimental period of 9' months (the period of sudden rise of occurrence 
rate of sarcomas) (Table 2). 
   II. Group treated with 2-10 injections: 
   Inflammatory signs or pictures of new-formation of the osteal tissue 
were seen in all cases but no evidence of tumor was noticed (Table 2). 
   III. Group treated with 11-20 injections : 
   The animal # 44 was treated with 13 injections. In this case the 
area of injection was grossly white and increased in consistency (Fig. 
2), and histologically, chronic proliferation of bony trabeculae associated 
with irregular proliferation of rather hypochromic, spindle-shaped, 
roughly round, young cells with occasional patches of osteoid stroma, 
i. e. , the early picture of osteogenic sarcoma was seen (Fig. 3). The 
animal # 26 which was treated with 19 injections developed a fracture of 
the femur 30 days before the final injection. After the final injection it 
developed an induration about 3 cm. in diameter and began to limp. After 
that the tumor increased in size to about 8 x 8 cm. (Fig. 4&5). This was 
confirmed as osteogenic sarcoma histologically. In the animal # 38 slight
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                         Table 2. 
          Reactions of the bone in cases of BeO injection 
                (Figures represent animal number)
1 2 - 10 11 - 2021
42: 66
43
Number of BeO injectionI 1 - 30 31 - 40 41 -
Reaction not noticeable
Degenerative change 17
, 22 4(Non-tumorous reaction)
Reaction with noticeable 41, 46 25 40
inflammation 55, 62 53 60
(Non-tumorous reaction) 155 _
Reaction composed mainly 45 19, 34








26, 3132, 35Osteogenic sarcoma
(Tumorous reaction) 57 , 70 5037, 39 10, 67 3, 11
Chondrosarcoma
(Tumorous reaction) 36, 65
Osteochondrosarcoma 20 16, 27 13 12








swelling with induration was noticed in the injected area of the femur,
and a cartilage-firm tumor measuring approximately 5 x 4 x 4 cm. was
seen in the head of the femur, far from the injected area (Fig. 6).
This was disclosed as osteogenic sarcoma histologically. In the animal
# 56 an induration aboutin diameter was noticed 20 days after
the 19th injection, and the animal died 30 days after the final injection.
Histologically, this was found to be an osteogenic sarcoma with less
tendency to osteogenesis (Fig. 7). The animals # 20, # 31 and # 70 also
showed typical pictures of osteogenic sarcoma or osteochondrosarcoma
(Fig. 8).
IV. Group treated withinjections .
Of 13 cases, tumors were seen in all cases except for 2 cases of
early deathin case the total experimental period is defined as 9
months). In the animal # 27 an induration approximately 3 cm. in
diameter was noticed 20 days after theinjection. X-ray of the
thigh showed osteogenic tumors approximately 5 x 4 x 4 cm. in the knee
area and at the upper end of the femur, far from the injected area
(Fig. 9). These were osteochondrosarcoma histologically, and metastatic
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lesions were seen in the lungs. In the animal # 30 a calcified lesion 
approximately 3 cm. in diameter was seen at the end of the femur, 
particularly in the flexor aspect, 90 days after the 22 nd injection (Fig. 
10). The tumor gradually increased in size after that. A month later, 
the toes became ulcerated and began to bleed followed by paralysis of 
the legs. When slaughtered the tumor was about 9 x 6 x 4 cm. and 
bone-like in consistency, and there were many soy-bean sized, firm, 
white metastatic lesions in the lungs. The primary lesion was revealed 
as osteochondrosarcoma but the metastatic lesions in the lungs and 
liver were composed of loose connective tissue with irregular intercell-
ular spaces filled with mucoid fluid, presenting an appearance resembling 
that of myxosarcoma, but chondroblasts were occasionally interlaced 
(Fig. 11). In the animal # 65 a tumor of the bone was found 192 days 
after the 22 nd injection. The tumor increased in size to about 7 x 6 x 4 
cm. 234 days after the final injection, and at the same time a sponta-
neous fracture of the bone was noticed. Autopsy revealed a cartilage-
firm tumor with rather soft, white cut surfaces, and histologic exami-
nation disclosed it to be a chondrosarcoma consisted mostly of markedly 
polymorphic young chondrocytes (Fig. 12). The metastatic lesions of 
the lungs, kidneys and lymph nodes of the lumbar region presented the 
same findings. In the animal # 35 a firm tumor approximately 3 cm. in 
diameter was noticed 22 days after the 24th injection. After that the 
tumor increased in size to approximately 1.0 x 10 x 8 cm. involving the 
entire femur (Fig. 13). It was histologically an osteogenic sarcoma. 
The animal # 32 developed a spontaneous fracture and began to limp 
73 days after the 25th injection. On the X-ray film taken 193 days 
after the final injection the tumor had involved the entire femur in 
association with marked osteogenesis (Fig. 14). Histologically, the 
tumor was an osteogenic sarcoma consisted of polymorphic cells, and 
numerous metastatic lesions varying in diameter from 0.5 cm. to 1.0 
cm. were seen in the lungs (Fig. 15). The animals # 16, # 33, # 36, 
# 37, # 39 and # 50 also showed osteogenic sarcoma, chondrosarcoma 
or chondroosteosarcoma (Table 1 & 2). 
   V. Group treated with 31-40 injections : 
   Evidence of malignant tumors was noticed in 3 out of 6 cases ( # 
10, # 13 and # 67) (Table 1). 
   VI. Group treated with more than 40 injections : 
   Slight swelling was noticed in the injected area in the animals # 
11 and # 12. Malignant transformation was noticed only histologically 
in the area of the bone marrow. In the animal # 3 a tumor was noticed 
254 days after the 43 rd injection. After that the tumor gradually 
increased in size involving the entire femur (Fig. 16) . Histologically, 
this was an osteogenic sarcoma with rather marked new-formation of 
bony trabecuiae (Fig. 17). Metastatic lesions were seen in the lungs 
and liver, and these lesions all showed active osteogenesis (Fig. 18).
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                    DISCUSSION 
   1) Summary of early changes caused by injection of BeO : 
   Under the author's experimental conditions, BeO was seen thro-
ughout the bone marrow 5 hours after the initial injection but no tissue 
reaction was noticed. However, more than 10 hours after the injection 
an increase of granulocytic young cells or young megakaryocytes was 
seen in many cases in addition to leukocytic reaction. Moreover, focal 
proliferation of young mesenchymal cells which seemed to have been 
derived from reticulocytic cells was shown. Particularly in the animal 
slaughtered 4 days after the injection, marked proliferation of spindle-
shaped mesodermic cells which presented a picture similar to that of 
sarcoma was seen around the injected BeO. In the animal # 61 abnormal 
proliferation of osteoblastic cells accompanied by frequent karyokinesis, 
and in the animal # 44 marked proliferation of bony trabeculae was 
seen in addition to that. These pictures were all interpreted as presar-
coma or early stage of sarcoma. These are considered to be the results 
of biological transformations caused by chemical or physical specific 
action of BeO on the mesodermic tissue. It is considered that if true 
sarcoma develop from these abnormal. tissues, these osteoblasts might 
get mutation during the procedure of their proliferation and be led to
Fig. 19. Relationship between the number of injections 
           and the period from the final injection to the 
           first notice of tumors.
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malignant transformation, acquiring unusual energy. 
   2) Periods of the production and the production rate of malignant 
tumors : 
   In the author's experiments, tumors transformation was noticed in 
8 out of 9 animals of the group treated with 11-20 injections, which 
survived for more than 9 months. The remaining one died accidentally. 
The picture of sarcoma was seen histologically in 7 out of these 8 
animals. Tumors were produced in all 11 animals of the group treated 
with 21 - 30 injections, which survived for more than 9 months. As 
shown in Table 2, the production of tumors is concentrated to this 
group. The average period from the final injection to the first notice 
of tumors was 12 weeks. But there is no distinct relationship between 
these periods and the number of injections (Fig. 19). In the experiments 
by KELLY et al. the production of tumors was noticed after 30 to 52 
weeks . after the final injection in the group treated with a total of 20 intra-
venous injections, 2 injections a week. However, in the author's experi-
ments, tumors were produced in less than half the period after the final
Fig. 20. Relationship between the first notice of tumors and 
           the periods from the initial injection and from the
           final injection to the first notice of tumors.
Period from the first notice of tumors to death (or slaughter; 
period from the final injection to the first notice of tumors 
Period of injection
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injection. The durations of injection, periods from the final injection 
to the first notice of tumors and total experiment-periods in cases 
having macroscopic tumors are showed in Fig. 20. Tumors were 
produced in a rather small number of animals among those treated with 
more than 30 injections : 3 out of 6 animals of the group treated with 
31-40 injections and 3 out of 4 animals of the group treated with more 
than 40 injections. On the basis of the fact that the groups treated with 
more than 30 injections required the same or a longer period from the 
final injection to the production of tumors in comparison with the group 
treated with 21 - 30 injections, the treatment with 20 - 30 injections is 
the best method which the author would like to recommend. 
   3) Metastases of sarcoma : 
   In the author's experiments, metastases were seen in 15 out of 24 
animals with sarcoma, about 62 %. As shown in Table 3, metastasis 
to the lung was seen in all 15 cases. Other than that, metastasis were 
seen also in the liver, kidneys and lymph nodes of the lumbar region. 
In the most severe case, as shown in Fig. 15 the majority of the lung
         Table 3. 






Animal L. N, s of Histologic picturesSpleen 
gLivernumbern of metastatic lesions.






20 + - Chondrosarcoma
26 + - Osteoid sarcoma
27 + - Osteogenic sarcoma
Myxosarcoma30 -H-
31 + - - - - Osteogenic sarcoma
32- Osteogenic sarcoma
33 + + Myxosarcoma
35 + -Osteogenic sarcoma
36 + - Osteogenic sarcoma
37 + - Osteoid sarcoma
38 * - Osteogenic sarcoma
39 - -
50 - -
56 -H- - Osteogenic sarcoma
57 - -
65 {}f- +Chondrosarcoma
67 + - Osteogenic sarcoma
70 - - - - I-
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parenchyma was occupied by metastic lesions. Histologically, the meta-
static lesion were composed of young tissues in comparison with the 
primary lesions. But the metastatic lesions in the lymph nodes were 
particularly firm and showed osteal tissue in large amounts. 
                    SUMMARY 
   1) By experimental BeO-injection in the bone marrow, out of 30 
rabbits which survived for more than 9 months 25 cases (84%) developed 
osteogenic sarcoma, chondrosarcoma or presarcomatous changes. 
   2) Metastatic lesions were noted mostly in the lung, but occasion-
ally also in the liver, kidneys and lymph nodes. The frequency of 
metastasis was found to be 68%. 
   3) The number of rabbits developing tumors were as follows: 
   11-20 injections : 8 of 9 (87%), 21-30 injections: 11 of 11 (100%), 
31-40 injections: 3 of 6 (50%), and over 41 injections: 3 of 4 (75%). 
Two injections of beryllium per week for a total of 21-30 doses appears 
to be the most effective schedule for the production of sarcomas. It 
should be noteworthy that there were some cases in which only micro-
scopic examination could detect the sarcoma although no sign of tumor 
was noticed macroscopically. 
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                  EXPLANATION OF FIGURES 
 Fig. 1. Histologic picture of the femur of animal #61 (4 days after the initial 
           injection). Immature mesodermic cells are irregularly arranged around 
           the homogenous mass of BeO on the right. H. E. 
 Fig. 2. #44 (treated with 13 injections. 247 days after the final injection). A 
           bone-firm area is seen in the lower one third. (arrowed) 
 Fig. 3. Histologic picture of the same case. Spindle-shaped, roughly round, 
           young cells are irregularly proliferating accompanied by small bony 
            trabeculae. H. E. 
 Fig. 4. # 26 (treated with 19 injections). X-ray picture taken 350 days after the 
           initial injection. A tumor mottled with areas of various degrees of
           density associated with a fracture is seen in the lower half of the 
         thigh. 
 Fig. 5. Photograph of the sarcoma of the same case. 
 Fig. 6. X-ray picture of animal #38 (died 43 days after the 19th injection) 
          taken 375 days after the initial injection. Swelling of the lower end of 
           the thigh and a hen's egg-sized, light, tumorous shadow near the head
           of the femur. 
 Fig. 7. #56 (died 50 days after the 19th injection). Histologic picture of the 
           tumor of the thigh. Sarcomatoid proliferation of spindle-shaped cells.
           New-formation of osteoid tissue is seen in the upper portion. H. E. 
 Fig. 8. 031 (treated with 17 injections). X-ray picture taken 156 days after 
           the final injection. A large tumor involving the entire length of the
            femur. 
 Fig. 9. # 27 (slaughtered 50 days after the 24th injection). X-ray picture taken 
           326 days after the initial injection. Osteal tumors are seen near the 
          injected area (upper portion) and at the head (lower portion). 
 Fig. 10. X-ray picture of #30 taken 90 days after the final (22nd) injection. A 
           tumor of increased density is seen with the lower end of the femur as
           the center. 
 Fig. 11. The same case. Metastatic lesions in the liver. Irregular-shaped 
           (spindle-shaped or round) cells are coarsely proliferating, presenting 
           a picture which resembles that of myxoma. Chondroblast-like cells 
            also are interlaced. H. E. 
 Fig. 12. Tumor of the thigh of #65 (slaughtered 234 days after the 22nd inject-
           ion). Composed of markedly polymorphic young cartilagenous cells.
            H. E. 
 Fig. 13. Tumor of the thigh of #35 (112 days after the 24th injection).
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 Fig. 14. #32. (treated with 25 injections). X-ray picture taken 193 days after 
            the final injection. Tumorous transformation is marked throughout 
          the thigh. 
 Fig. 15. Metastatic lesions of the lungs of the same case. 
 Fig. 16. # 3 (4o4 days after the 43rd injection). Cut surface of the tumor of 
          the thigh. 
 Fig. 17. Histologic picture of the same case. Rather large bony trabeculae and 
           irregular proliferation of osteoblasts are seen. 
 Fig. 18. Metastatic lesions of the lung of the same case.. Peripheral sarcoma-
           tous cells are very young but the bony trabeculae of the central 
           region (lower portion) are rather highly differentiated.
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